UBS analyst Thyra Lee initiated coverage of Ambu (AMBFF) with a Buy rating and DKK 147 price target The company is set to deliver mid-teens sales and mid-20s earnings growth, driven by its leading ability to win in the shift from reusable to single-use endoscopes, the analyst tells investors in a research note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMBFF: